Molecular Therapy — Nucleic Acids is an international, open-access journal publishing top-quality basic, translational, and clinical research in the broad fields of nucleic acid-based therapeutics to treat and/or correct genetic and acquired disease. Subject areas include but are not limited to: development of therapeutics based on nucleic acids and their derivatives, vector development and design for the delivery of RNA-based therapeutics, applications of gene-modifying agents including triplex-forming oligonucleotides and enzymes such as Zn finger nucleases, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy – Nucleic Acid’s 2018 impact factor is 5.919.
Other key topics include:
Applications of DNA-based oligonucleotides and their derivatives
Gene vectors for delivery of RNA-based therapies
Development of nanoparticles and other delivery agents
siRNAs, shRNAs, and miRNAs
Aptamers, ribozymes, and DNAzymes
Peptide nucleic acids
Gene-modifying approaches including enzymes, triplex-forming nucleic acids, and other approaches
Development of new nucleic acid chemistries for altering gene expression
Mechanisms of gene and nucleic acid transfer/transfection
Vector trafficking and biodistribution